Hello All, Super excited to be making my first post in the community. I've been disease modifying therapy and symptom-free from RRMS for 8 years and counting now. In July, I had an opportunity to meet with my gastric surgeon, Dr. Charles Procter Jr. to share with him that I had found the cause and cure for my type of M.S. He has always treated me as a peer even though I'm not a doctor yet. He was happy for me and asked me if I had done my paper yet. I told him I was working on it, but hadn't prioritized it over making the web series. He said I needed to get my paper done and then start thinking about a speaking circuit. I took his advice and for two solid months worked on getting my research paper completed and published. My first peer-review by the managing editor was eye opening. My paper was super prideful and didn't account for every detail that my 25 year Internal Audit background had prepared me for. Denzel Washington said it best in the movie Training Day, "It's not what you know, it's what you can prove." I went back to the drawing board and had Chat GPT validate each of my conclusions as I reached them. Second time around, I got the same managing editor and was psyched because it was like getting to the boss at the end of video games. Submitted my revamped super-paper on November 5th and got feedback November 17th at 9:40 A.M. This time, I got a whole different kind of response that let me know I was on to something. Take a look at the email from the journal below: ----------------------------------------------------------------------------------------------------------------------------------------------------- Email 1: Ms. Ref. No.: MSARD-D-25-01351 Title: Novel Therapeutic Pathways in Multiple Sclerosis: Evidence for a Peripheral Nervous System–Led Model of Disease Initiation Multiple Sclerosis and Related Disorders Dear Mr. Dhata R Harris, Thank you for submitting your manuscript to Multiple Sclerosis and Related Disorders. I regret to say that we are not persuaded that your findings fit well with the mission of Multiple Sclerosis and Related Disorders.